Amy N. Luckenbaugh MD

Assistant Professor
Department of Urology
Division of Urologic Oncology

Medical Degree: State University of New York at Buffalo
Residency: University of Michigan
Fellowship: Vanderbilt University Medical Center
Clinical Interests: Bladder Cancer, Kidney Cancer, Prostate Cancer, Testis Cancer, Urologic Cancer

Dr. Luckenbaugh is a high-volume surgeon whose clinical focus centers around the comprehensive care of patients with urologic malignancies. She currently serves as a member of the Society of Women in Urology board, and through her research aims to mitigate variation in healthcare delivery.

Active Clinical Trials

Taris Biomedical-MIBC

A Multicenter Study Evaluating Safety and Efficacy of TAR-200 in Subjects with Muscle-Invasive Urothelial Carcinoma of The Bladder Who are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who are Unfit for Radical Cystectomy

Learn more about this study

PI: Amy Luckenbaugh, MD

FKD Therapies/Instiladrin

A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

Learn more about this trial

PI: Amy Luckenbaugh, MD

Female Cystectomy

Sexual Function in Women after Radical Cystectomy.

PI: Amy Luckenbaugh, MD